Article
Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
Pharmacogenetics and genomics - 1 Oct 2013
De Mattia Elena, Toffoli Giuseppe, Polesel Jerry, D'Andrea Mario, Corona Giuseppe, Zagonel Vittorina, Buonadonna Angela, Dreussi Eva, Cecchin Erika
Abstract excerpt
OBJECTIVE: Membrane transporters are widely recognized as important determinants of drug disposition and response, generating increasing interest on the pharmacological implications of their genetic variations. The aim of this study was to elucidate the predictive/prognostic role of ATP-binding cassette (ABC) and solute carrier (SLC) protein polymorphisms on irinotecan (FOLFIRI regimen) outcome. PATIENTS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
